TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T94627	Solute carrier family 28 member 2	B19UZC	5'-o-Acetyladenosine	Investigative	11953391	C12H15N5O5	309.28	CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B1DZU9	(2R,3R,4S,5R)-2-[6-Amino-8-[(2-methylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	Investigative	118737953	C18H22N6O4	386.4	CC1=CC=CC=C1CNC2=NC3=C(N=CN=C3N2[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	IC50 = 65000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B2D5BV	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl ethyl carbonate	Investigative	22803321	C13H17N5O6	339.3	CCOC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B2XI4P	Adenosine-derived inhibitor, 6	Investigative	13965968	C17H20N6O4	372.4	C1=CC=C(C=C1)CNC2=NC3=C(N=CN=C3N2[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	IC50 = 52000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B3XZA8	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexanoate	Investigative	118737964	C16H23N5O5	365.38	CCCCCC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B46CVH	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-benzylcarbamate	Investigative	118737970	C18H20N6O5	400.4	C1=CC=C(C=C1)CNC(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B4I3BY	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 2-phenylacetate	Investigative	118737965	C18H19N5O5	385.4	C1=CC=C(C=C1)CC(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B4T7FD	(2R,3R,4S,5R)-2-[6-Amino-8-[(2-methoxyphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	Investigative	118737959	C18H22N6O5	402.4	COC1=CC=CC=C1CNC2=NC3=C(N=CN=C3N2[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B6KBW9	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-pentylcarbamate	Investigative	118737969	C16H24N6O5	380.4	CCCCCNC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	B74ZSC	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-methylcarbamate	Investigative	56975630	C12H16N6O5	324.29	CNC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	BEP49S	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl methyl carbonate	Investigative	118737966	C12H15N5O6	325.28	COC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	BGD26U	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl benzyl carbonate	Investigative	118737968	C18H19N5O6	401.4	C1=CC=C(C=C1)COC(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	BL6HE1	Propionyl adenylate	Investigative	11544329	C13H17N5O5	323.3	CCC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	BR25AM	(2R,3R,4S,5R)-2-[6-Amino-8-[(2-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	Investigative	118737962	C23H24N6O4	448.5	C1=CC=C(C=C1)C2=CC=CC=C2CNC3=NC4=C(N=CN=C4N3[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O)O)N	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	BU4I9J	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl pentyl carbonate	Investigative	118737967	C16H23N5O6	381.38	CCCCCOC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	BYMX06	[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-ethylcarbamate	Investigative	46887269	C13H18N6O5	338.32	CCNC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	IC50 ~ 100000 nM	Poor binder
T94627	Solute carrier family 28 member 2	D06WAL	Phlorizin	Investigative	6072	C21H24O10	436.4	C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O	IC50 = 100000 nM	Poor binder